SQZ Biotech to Present at November Virtual Investor Conferences

On November 12, 2020 SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, reported that Armon Sharei, PhD, chief executive officer of SQZ, and additional management will participate in the following upcoming virtual investor conferences (Press release, SQZ Biotech, NOV 12, 2020, View Source [SID1234570824]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2020 Virtual Healthcare Conference
Tuesday, November 17, 2020
Presentation Time: 1:20 pm EST
Webcast available

Jefferies Virtual London Healthcare Conference
Thursday, November 19, 2020
Presentation Time: 7:55 am EST/12:55 pm GMT
Webcast available

The live webcast of SQZ’s presentations can also be accessed through the "Events & Presentations" page within the Investors & Media section of the SQZ website. Replays of the webcast will be available on the SQZ website for 90 days following the event.